Purchase Order 75N93024P00792
Award Date
6/28/24
Potential Completion Date
2/27/25
Potential Value
$41K
Federal Agency
National Institute of Allergy and Infectious Diseases
Awardee
Illumina, Inc.
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Bethesda, MD 20892, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
3
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Illumina, Inc., a manufacturer of genomic sequencing instruments and reagents. The contract, valued at $4,037.50, is for the delivery of Illumina's NextSeq, NovaSeq, MiSeq, and iSeq sequencing systems, along with accompanying reagents, consumables, and support services. The contract has no set-aside designation....
This is a $14,997.46 firm fixed price delivery order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to Illumina, Inc., a for-profit manufacturer of genetic analysis instruments and reagents. The contract is not set aside for any specific business size or type. Under this award, Illumina will provide a range of its NextSeq, NovaSeq, MiSeq, and iSeq sequencing systems, as well as accompanying reagents, consumables, sample preparation kits,...
This is a firm fixed-price delivery order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Illumina, Inc., a manufacturer of genetic sequencing instruments and reagents. The contract, valued at $91,472.77, is for the provision of reagents and consumables to support Illumina's sequencing platforms, including NextSeq, NovaSeq, MiSeq, and iSeq systems. This appears to be a standing purchase order without a...
This is a $119,060.18 firm fixed price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services, to Illumina, Inc. for the provision of an MISEQ2 sequencing instrument and associated reagents. The contract has no set-aside designation. Illumina, a manufacturer of genetic analysis instruments and reagents, has been awarded multiple prior federal contracts and sub-grants to provide...
This is a firm fixed price delivery order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Illumina, Inc., a manufacturer and provider of genetic and genomic analysis solutions. The $5,834.40 order is for the provision of Illumina's sequencing instruments, reagents, and services, including NextSeq, NovaSeq, MiSeq, and iSeq systems. These products and services support genomic sequencing and analysis for...
This is a $6,935.22 firm fixed-price purchase order contract awarded to Illumina, Inc., a manufacturer of sequencing and array-based genomic analysis solutions, by the National Institute of Allergy and Infectious Diseases (NIAID), an agency of the National Institutes of Health (NIH). The contract, which has no set-aside designation, is for the provision of sequencing systems, reagents, and services to support genomic research and diagnostics across various federal agencies. Illumina has...
This is a $863,550.00 firm fixed price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID) within the National Institutes of Health (NIH) to Illumina, Inc. for the provision of lab equipment, including NextSeq, NovaSeq, MiSeq, and iSeq sequencing systems, reagents, and other consumables. Illumina is a manufacturer and provider of genomic sequencing and analysis solutions. The award has no set-aside designation. Illumina has a history of providing...
This is a firm fixed price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services, to Illumina, Inc. for a renewal service agreement to support two Illumina NextSeq sequencing systems. The contract has a ceiling value of $74,756.41 and a period of performance through March 20, 2026. There is no set-aside designation for this award. Illumina is a manufacturer of genomic sequencing...
The Department of Health and Human Services' National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) awarded a firm fixed price purchase order to Illumina, Inc., a for-profit manufacturer of genomic sequencing systems and reagents. The $101,340.96 contract provides a one-year service plan for Illumina's NextSeq and MiSeq sequencing platforms, as well as an iSeq 100 system, to be used at an NIAID facility in Frederick, Maryland. The contract was...
This is a firm fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services, to Illumina, Inc., a for-profit manufacturer of genomic sequencing instruments and reagents. The contract, valued at $12,875.00, is for sequencing services to support NIAID's research and diagnostic efforts. Illumina has previously been awarded other prime federal contracts and subcontracts by...